LGVN
Price
$1.51
Change
+$0.01 (+0.67%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
22.51M
PROK
Price
$5.19
Change
+$0.85 (+19.59%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
562.19M
27 days until earnings call
Interact to see
Advertisement

LGVN vs PROK

Header iconLGVN vs PROK Comparison
Open Charts LGVN vs PROKBanner chart's image
Longeveron
Price$1.51
Change+$0.01 (+0.67%)
Volume$100
Capitalization22.51M
ProKidney
Price$5.19
Change+$0.85 (+19.59%)
Volume$226.49K
Capitalization562.19M
LGVN vs PROK Comparison Chart in %
Loading...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LGVN vs. PROK commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGVN is a Hold and PROK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (LGVN: $1.50 vs. PROK: $4.34)
Brand notoriety: LGVN and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LGVN: 261% vs. PROK: 1569%
Market capitalization -- LGVN: $22.51M vs. PROK: $562.19M
LGVN [@Biotechnology] is valued at $22.51M. PROK’s [@Biotechnology] market capitalization is $562.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LGVN’s FA Score shows that 1 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • LGVN’s FA Score: 1 green, 4 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, LGVN is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LGVN’s TA Score shows that 5 TA indicator(s) are bullish while PROK’s TA Score has 7 bullish TA indicator(s).

  • LGVN’s TA Score: 5 bullish, 4 bearish.
  • PROK’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, PROK is a better buy in the short-term than LGVN.

Price Growth

LGVN (@Biotechnology) experienced а +15.38% price change this week, while PROK (@Biotechnology) price change was +649.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.89%. For the same industry, the average monthly price growth was +16.25%, and the average quarterly price growth was +20.89%.

Reported Earning Dates

LGVN is expected to report earnings on May 08, 2025.

PROK is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+9.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PROK($562M) has a higher market cap than LGVN($22.5M). PROK YTD gains are higher at: 206.509 vs. LGVN (-13.295). LGVN has higher annual earnings (EBITDA): -16.49M vs. PROK (-160.12M). PROK has more cash in the bank: 328M vs. LGVN (14.3M). LGVN has less debt than PROK: LGVN (1.3M) vs PROK (3.37M). LGVN has higher revenues than PROK: LGVN (2.23M) vs PROK (306K).
LGVNPROKLGVN / PROK
Capitalization22.5M562M4%
EBITDA-16.49M-160.12M10%
Gain YTD-13.295206.509-6%
P/E RatioN/AN/A-
Revenue2.23M306K727%
Total Cash14.3M328M4%
Total Debt1.3M3.37M38%
TECHNICAL ANALYSIS
Technical Analysis
LGVNPROK
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
60%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 2 days ago
72%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 10 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FERGX15.70N/A
N/A
Fidelity SAI Emerging Markets Index
UEPIX17.71N/A
N/A
ProFunds Europe 30 Inv
UGMVX11.82N/A
N/A
Victory Global Managed Volatility
GSMVX16.76N/A
N/A
Goldman Sachs Small/Mid Cap Equity Instl
VLNPX41.76N/A
N/A
Voya Small Cap Growth R6

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with QURE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
N/A
QURE - LGVN
36%
Loosely correlated
+0.07%
SNGX - LGVN
34%
Loosely correlated
+1.60%
PROK - LGVN
34%
Loosely correlated
+19.35%
SRPT - LGVN
34%
Loosely correlated
-1.57%
LGND - LGVN
32%
Poorly correlated
+2.11%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with NRIX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
+19.35%
NRIX - PROK
39%
Loosely correlated
-3.87%
CGON - PROK
39%
Loosely correlated
+0.26%
APGE - PROK
38%
Loosely correlated
+4.19%
CGEM - PROK
37%
Loosely correlated
+0.51%
KYMR - PROK
37%
Loosely correlated
+0.07%
More